Kelendia Tablets 10mg, manufactured by Bayer Pharmaceutical, contain Finerenone, a non-steroidal mineralocorticoid receptor antagonist (MRA). With YJ code 2190044F1020 and a standard of 10mg per tablet, it is used to reduce the risk of kidney function decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.
Kelendia Tablets 10mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →